{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:33:18Z","timestamp":1786120398905,"version":"build-2736575974"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>\n                      This study evaluated the clinical efficacy of a pharmacist-led antimicrobial stewardship program augmented by metagenomic next-generation sequencing (mNGS) for managing rare, multidrug-resistant\n                      <jats:italic toggle=\"yes\">Elizabethkingia<\/jats:italic>\n                      keratitis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      We conducted a retrospective case series of 5 male patients (mean age 56.4 years) diagnosed with\n                      <jats:italic toggle=\"yes\">Elizabethkingia<\/jats:italic>\n                      keratitis (3\n                      <jats:italic toggle=\"yes\">E. meningoseptica<\/jats:italic>\n                      , 2\n                      <jats:italic toggle=\"yes\">Elizabethkingia anophelis<\/jats:italic>\n                      ) between 2020 and 2025. Initial microbiological identification relied on corneal scraping culture and MALDI-TOF MS, while mNGS was strategically used in 1 complex case to identify potential copathogens. Clinical pharmacists provided interventions including minimum inhibitory concentration\u2013guided therapy and the extemporaneous preparation of fortified antibiotic eye drops, such as 2% amikacin and 10% piperacillin\/tazobactam. We assessed clinical outcomes, visual acuity (LogMAR), and the length of hospital stay.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Although conventional culture confirmed\n                      <jats:italic toggle=\"yes\">Elizabethkingia<\/jats:italic>\n                      species in all cases, mNGS offered critical genomic insights in 1 complex case by detecting culture-negative co-pathogens\n                      <jats:italic toggle=\"yes\">Nocardia pneumoniae<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">Fusarium proliferatum<\/jats:italic>\n                      , which directly guided the addition of targeted antifungal and antibacterial therapy. All\n                      <jats:italic toggle=\"yes\">Elizabethkingia<\/jats:italic>\n                      isolates demonstrated extensive resistance to carbapenems and cephalosporins. After pharmacist-led interventions, mean visual acuity improved significantly from 1.56 \u00b1 0.77 to 0.90 \u00b1 0.25 LogMAR. Furthermore, the length of hospital stay decreased markedly from 40 days in the index case to an average of 10.7 \u00b1 4.9 days in the final 3 cases as diagnostic and therapeutic protocols were refined.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>\n                      Integrating clinical pharmacists within a multidisciplinary team, supported by mNGS for comprehensive polymicrobial detection, enables precision pharmacotherapy for multidrug-resistant\n                      <jats:italic toggle=\"yes\">Elizabethkingia<\/jats:italic>\n                      keratitis. This approach promotes successful ocular salvage and visual recovery while substantially improving clinical efficiency through shortened hospitalization.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ico.0000000000004249","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:42:11Z","timestamp":1786048931000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacist-Led Management of Elizabethkingia Keratitis: Precision Therapy Guided by Culture and mNGS to Improve Clinical Outcomes and Efficiency"],"prefix":"10.1097","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7429-7108","authenticated-orcid":false,"given":"Pengyuan","family":"Du","sequence":"first","affiliation":[{"name":"National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, China;"},{"name":"National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6320-8159","authenticated-orcid":false,"given":"Mengjie","family":"Zhou","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, China;"},{"name":"National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lusheng","family":"Wang","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, China;"},{"name":"National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9455-6901","authenticated-orcid":false,"given":"Xiaobi","family":"Zhang","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, China;"},{"name":"National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"R1-20260806","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1099\/ijs.0.63541-0","article-title":"Transfer of Chryseobacterium meningosepticum and Chryseobacterium miricola to Elizabethkingia gen. nov. as Elizabethkingia meningoseptica comb. nov. and Elizabethkingia miricola comb. nov","volume":"55","author":"Kim","year":"2005","journal-title":"Int J Syst Evol Microbiol."},{"key":"R2-20260806","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/ajcp\/31.3.241","article-title":"Studies on a group of previously unclassified bacteria associated with meningitis in infants","volume":"31","author":"King","year":"1959","journal-title":"Am J Clin Pathol."},{"key":"R3-20260806","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1128\/AAC.05835-11","article-title":"Carbapenem resistance in Elizabethkingia meningoseptica is mediated by Metallo-\u03b2-Lactamase BlaB","volume":"56","author":"Gonz\u00e1lez","year":"2012","journal-title":"Antimicrob Agents Chemother."},{"key":"R4-20260806","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3390\/microorganisms7090295","article-title":"Elizabethkingia infections in humans: from genomics to clinics","volume":"7","author":"Lin","year":"2019","journal-title":"Microorganisms"},{"key":"R5-20260806","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/ICL.0b013e318291d171","article-title":"Posttraumatic keratitis caused by Elizabethkingia meningosepticum","volume":"39","author":"Erdem","year":"2013","journal-title":"Eye Contact Lens"},{"key":"R6-20260806","doi-asserted-by":"crossref","first-page":"e937687","DOI":"10.12659\/AJCR.937687","article-title":"Post-keratoplasty infectious keratitis caused by Elizabethkingia meningoseptica","volume":"24","author":"Alfaraidi","year":"2023","journal-title":"Am J Case Rep."},{"key":"R7-20260806","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.clae.2013.07.011","article-title":"Massive lipid keratopathy after Elizabethkingia meningosepticum keratitis","volume":"37","author":"Li","year":"2014","journal-title":"Cont Lens Anterior Eye."},{"key":"R8-20260806","doi-asserted-by":"crossref","first-page":"8447","DOI":"10.1038\/s41598-018-26874-8","article-title":"Comparative genomic analysis of a naturally competent Elizabethkingia anophelis isolated from an eye infection","volume":"8","author":"Bulagonda","year":"2018","journal-title":"Sci Rep."},{"key":"R9-20260806","doi-asserted-by":"crossref","first-page":"e0263024","DOI":"10.1128\/spectrum.02630-24","article-title":"Etiological characteristics of 3,691 cases of microbial keratitis: an 8-year longitudinal study","volume":"13","author":"Xu","year":"2025","journal-title":"Microbiol Spectr."},{"key":"R10-20260806","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.cmi.2018.04.015","article-title":"Multicentre study evaluating matrix-assisted laser desorption ionization\u2013time of flight mass spectrometry for identification of clinically isolated Elizabethkingia species and analysis of antimicrobial susceptibility","volume":"25","author":"Cheng","year":"2019","journal-title":"Clin Microbiol Infect."},{"key":"R11-20260806","doi-asserted-by":"crossref","DOI":"10.21203\/rs.3.rs-31273\/v2","article-title":"Clinical characteristics of Elizabethkingia meningoseptica ophthalmic infections","author":"Leung","year":"2020"},{"key":"R12-20260806","doi-asserted-by":"crossref","first-page":"e0168221","DOI":"10.1128\/spectrum.01682-21","article-title":"The evolutionary trend and genomic features of an emerging lineage of Elizabethkingia anophelis strains in Taiwan","volume":"10","author":"Lee","year":"2022","journal-title":"Microbiol Spectr."},{"key":"R13-20260806","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.2147\/IDR.S536057","article-title":"Multidrug-resistant Elizabethkingia anophelis bacteremia in Northern Taiwan: focusing on prognostic factors and antimicrobial susceptibility to minocycline and rifampin","volume":"18","author":"Chuang","year":"2025","journal-title":"Infect Drug Resist."},{"key":"R14-20260806","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3390\/jcm7120538","article-title":"Comparison of clinical manifestations, antimicrobial susceptibility patterns, and mutations of fluoroquinolone target genes between Elizabethkingia meningoseptica and Elizabethkingia anophelis isolated in Taiwan","volume":"7","author":"Lin","year":"2018","journal-title":"J Clin Med."},{"key":"R15-20260806","doi-asserted-by":"crossref","first-page":"26045","DOI":"10.1038\/srep26045","article-title":"Elizabethkingia anophelis bacteremia is associated with clinically significant infections and high mortality","volume":"6","author":"Lau","year":"2016","journal-title":"Sci Rep."},{"key":"R16-20260806","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4103\/kjo.kjo_63_18","article-title":"Preparation of fortified antimicrobial eye drops","volume":"30","author":"Nixon","year":"2018","journal-title":"Kerala J Ophthalmol."},{"key":"R18-20260806","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/S0140-6736(13)60318-9","article-title":"First case of Elizabethkingia anophelis meningitis in the Central African Republic","volume":"381","author":"Frank","year":"2013","journal-title":"Lancet"},{"key":"R19-20260806","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.idnow.2022.05.005","article-title":"Elizabethkingia anophelis outbreak in France","volume":"52","author":"Guerpillon","year":"2022","journal-title":"Infect Dis Now."},{"key":"R20-20260806","doi-asserted-by":"crossref","first-page":"918907","DOI":"10.1155\/2014\/918907","article-title":"Neonatal meningitis by multidrug ResistantElizabethkingia meningosepticumIdentified by 16S ribosomal RNA gene sequencing","volume":"2014","author":"Shailaja","year":"2014","journal-title":"Int J Pediatr."}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/ICO.0000000000004249","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:42:13Z","timestamp":1786048933000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/ICO.0000000000004249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":19,"URL":"https:\/\/doi.org\/10.1097\/ico.0000000000004249","relation":{},"ISSN":["0277-3740","1536-4798"],"issn-type":[{"value":"0277-3740","type":"print"},{"value":"1536-4798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"assertion":[{"value":"2026-03-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}